Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30630772

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 Feb
First author
Bromberg JEC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Feb;20(2):169-170. doi: 10.1016/S1470-2045(18)30829-5.
    note
    Source null
    related pmid
    30630773
    relationship
    Comment in

Authors and identifiers

  1. name
    Bromberg JEC
    type
    Author
  2. name
    Issa S
    type
    Author
  3. name
    Bakunina K
    type
    Author
  4. name
    Minnema MC
    type
    Author
  5. name
    Seute T
    type
    Author
  6. name
    Durian M
    type
    Author
  7. name
    Cull G
    type
    Author
  8. name
    Schouten HC
    type
    Author
  9. name
    Stevens WBC
    type
    Author
  10. name
    Zijlstra JM
    type
    Author
  11. name
    Baars JW
    type
    Author
  12. name
    Nijland M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bromberg JEC
    type
    Author
  2. name
    Issa S
    type
    Author
  3. name
    Bakunina K
    type
    Author
  4. name
    Minnema MC
    type
    Author
  5. name
    Seute T
    type
    Author
  6. name
    Durian M
    type
    Author
  7. name
    Cull G
    type
    Author
  8. name
    Schouten HC
    type
    Author
  9. name
    Stevens WBC
    type
    Author
  10. name
    Zijlstra JM
    type
    Author
  11. name
    Baars JW
    type
    Author
  12. name
    Nijland M
    type
    Author
bibliography ids
  1. nci-bib-02d1434c7b4bdb09017c57c0
book metadata
content sha256
19f4ac2482c7af4e2a04e16446f661ce6d5dd53c9b0205869d848d408e9afb55
document type
citation
dois
  1. 10.1016/S1470-2045(18)30747-2
electronic publication date
display
2019 Jan 7
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30630772
immutable id
pubmed:30630772@19f4ac2482c7af4e2a04e16446f661ce6d5dd53c9b0205869d848d408e9afb55
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
216-228
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Feb;20(2):169-170. doi: 10.1016/S1470-2045(18)30829-5.
    note
    Source null
    related pmid
    30630773
    relationship
    Comment in
outcomes validated
false
pmid
30630772
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
a494cfee621709538ef7939aa21e66f7d6dfc2be2236803888f62c20ccd827a4
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Feb
precision
month
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30630772/
title
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

Preserved source evidence · Not medical advice